ピラマル・ファーマ・ソリューションズと味の素バイオファーマサービスは、基本的に一つのことを目的とした提携を発表しました。抗体薬物複合体医薬品の早期開発から実際の商業化までの期間を短縮することです。
Mitsubishi Logistics Corporation, Mitsubishi Corporation, and Yourstand Inc. are set to introduce…
NEC Orchestrating Future Fund, an ecosystem-based corporate venture capital (CVC) fund, has…
Cardinal Health Inc. began selling the Kangaroo OMNI Pump, a state-of-the-art enteral…
Enyu Pharma Co., Ltd., which aims to develop medicines for diseases for…
Takeda Pharmaceutical Company Limited announced today that its Board of Directors unanimously…
Pharmashift Inc. is pleased to announce that its "Tsunagari Pharmacy" has partnered…
FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery Using Drug Discovery…
Mitsubishi Logistics Corporation, Mitsubishi Corporation, and Yourstand Inc. are set to introduce…
NEC Orchestrating Future Fund, an ecosystem-based corporate venture capital (CVC) fund, has…
Cardinal Health Inc. began selling the Kangaroo OMNI Pump, a state-of-the-art enteral…
Enyu Pharma Co., Ltd., which aims to develop medicines for diseases for…
Takeda Pharmaceutical Company Limited announced today that its Board of Directors unanimously…
Pharmashift Inc. is pleased to announce that its "Tsunagari Pharmacy" has partnered…
FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery Using Drug Discovery…
アカウントにサインインする